ÂÜŔňÂŇÂ×

Karen Brown, PhD, JD is Senior Vice President, Intellectual Property & Legal Affairs of Prime Medicine, where she brings more than 20 years of experience in the life science industries. Before joining Prime, she served as senior vice president, IP & Legal Affairs at Obsidian Therapeutics, where she was a member of the leadership team, formulated the company’s IP strategy, and oversaw corporate legal matters. Prior to joining Obsidian, Dr. Brown was vice president and chief IP counsel at Ironwood Pharmaceuticals, where she built and led the IP group and developed the company’s global patent and trademark portfolio. While at Ironwood, Dr. Brown achieved successful outcomes in ANDA litigation for LINZESS® in collaboration with Ironwood’s co-development partner Allergan. Earlier in her career, Dr. Brown served in patent counsel roles of increasing responsibility at Vertex Pharmaceuticals, Schering-Plough, and in private practice.

Dr. Brown holds an AB in biology from Princeton University, a PhD in biochemistry from Boston University, and a JD from Fordham University School of Law.